Open · 286 days left D National Institutes of Health

Emerging Global Leader Award (K43 Independent Clinical Trial Required)

Funding
Not specified
Deadline
--
Days
--
Hrs
--
Min
--
Sec
Dec 03, 2026
Posted Oct 15, 2024 (492 days ago)
Closes Dec 3, 2026 (in 286 days)

Grant Details

Opportunity Number
PAR-24-295
CFDA / ALN
93.113, 93.172, 93.173, 93.233, 93.242, 93.279, 93.313, 93.398, 93.837, 93.838, 93.839, 93.840, 93.853, 93.866, 93.989
Opportunity Category
Discretionary (D)
Funding Category
ED, ENV, HL
Funding Instrument
Grant (G)
Cost Sharing
No Cost Sharing (No)

Eligibility

Others (25)

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); Applications for the K43 award must be submitted by academic education or research institutions in LMICs (as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups; low-income, lower-middle-income, and upper-middle-income countries are included). FIC's Country Eligibility Notice (NOT-TW-12-011 Notice of Change in Country Eligibility for Fogarty International Training Grants ) applies to this NOFO and states that for competing and re-competing research training grant applications (including the K43 mechanism), with the exception of Sub-Saharan African countries, FIC will no longer accept applications from, or applications that involve training of scientists from upper-middle-income countries that are also members of the G20 major economies (http://www.g20.org/en/members). For additional information see FIC's Country Eligibility page at https://www.fic.nih.gov/Grants/Pages/country-eligibility.aspx. Only non-domestic (non-U.S.) Entities (Foreign Institutions) in Low- or Middle-Income Countries are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Description

This is a reissue of the Emerging Global Leader Program (K43) to align with the clinical trials policy.